PortfoliosLab logo
FPHAX vs. PPH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FPHAX and PPH is 0.68, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

FPHAX vs. PPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Pharmaceuticals Portfolio (FPHAX) and VanEck Vectors Pharmaceutical ETF (PPH). The values are adjusted to include any dividend payments, if applicable.

250.00%300.00%350.00%400.00%450.00%500.00%December2025FebruaryMarchAprilMay
426.92%
275.71%
FPHAX
PPH

Key characteristics

Sharpe Ratio

FPHAX:

-0.63

PPH:

0.12

Sortino Ratio

FPHAX:

-0.73

PPH:

0.26

Omega Ratio

FPHAX:

0.91

PPH:

1.04

Calmar Ratio

FPHAX:

-0.45

PPH:

0.11

Martin Ratio

FPHAX:

-1.02

PPH:

0.25

Ulcer Index

FPHAX:

13.05%

PPH:

7.67%

Daily Std Dev

FPHAX:

21.07%

PPH:

15.59%

Max Drawdown

FPHAX:

-37.34%

PPH:

-46.49%

Current Drawdown

FPHAX:

-25.39%

PPH:

-11.08%

Returns By Period

In the year-to-date period, FPHAX achieves a -8.00% return, which is significantly lower than PPH's 1.56% return. Over the past 10 years, FPHAX has underperformed PPH with an annualized return of 1.05%, while PPH has yielded a comparatively higher 3.89% annualized return.


FPHAX

YTD

-8.00%

1M

2.59%

6M

-13.86%

1Y

-14.91%

5Y*

1.29%

10Y*

1.05%

PPH

YTD

1.56%

1M

5.82%

6M

-1.23%

1Y

0.48%

5Y*

9.71%

10Y*

3.89%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FPHAX vs. PPH - Expense Ratio Comparison

FPHAX has a 0.75% expense ratio, which is higher than PPH's 0.36% expense ratio.


Risk-Adjusted Performance

FPHAX vs. PPH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FPHAX
The Risk-Adjusted Performance Rank of FPHAX is 22
Overall Rank
The Sharpe Ratio Rank of FPHAX is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of FPHAX is 11
Sortino Ratio Rank
The Omega Ratio Rank of FPHAX is 22
Omega Ratio Rank
The Calmar Ratio Rank of FPHAX is 11
Calmar Ratio Rank
The Martin Ratio Rank of FPHAX is 22
Martin Ratio Rank

PPH
The Risk-Adjusted Performance Rank of PPH is 2525
Overall Rank
The Sharpe Ratio Rank of PPH is 2727
Sharpe Ratio Rank
The Sortino Ratio Rank of PPH is 2424
Sortino Ratio Rank
The Omega Ratio Rank of PPH is 2424
Omega Ratio Rank
The Calmar Ratio Rank of PPH is 2727
Calmar Ratio Rank
The Martin Ratio Rank of PPH is 2424
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FPHAX vs. PPH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current FPHAX Sharpe Ratio is -0.63, which is lower than the PPH Sharpe Ratio of 0.12. The chart below compares the historical Sharpe Ratios of FPHAX and PPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50December2025FebruaryMarchAprilMay
-0.63
0.12
FPHAX
PPH

Dividends

FPHAX vs. PPH - Dividend Comparison

FPHAX's dividend yield for the trailing twelve months is around 1.44%, less than PPH's 1.95% yield.


TTM20242023202220212020201920182017201620152014
FPHAX
Fidelity Select Pharmaceuticals Portfolio
1.44%1.90%8.08%5.18%11.09%8.85%8.33%1.97%1.62%1.07%12.80%10.72%
PPH
VanEck Vectors Pharmaceutical ETF
1.95%1.98%2.09%1.55%1.62%1.66%1.77%1.97%1.92%2.43%1.93%1.71%

Drawdowns

FPHAX vs. PPH - Drawdown Comparison

The maximum FPHAX drawdown since its inception was -37.34%, smaller than the maximum PPH drawdown of -46.49%. Use the drawdown chart below to compare losses from any high point for FPHAX and PPH. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%December2025FebruaryMarchAprilMay
-25.39%
-11.08%
FPHAX
PPH

Volatility

FPHAX vs. PPH - Volatility Comparison

Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a higher volatility of 11.21% compared to VanEck Vectors Pharmaceutical ETF (PPH) at 8.41%. This indicates that FPHAX's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%December2025FebruaryMarchAprilMay
11.21%
8.41%
FPHAX
PPH